Table 1 Characteristics of included patients
Age Mean ± SD (range) | 46.11 ± 17.16 (15 – 80) |
Gender | |
Males | 60 (58.25%) |
Females | 43 (41.75%) |
Performed procedure | |
Esophago-gastro duodenoscopy (OGD) | 44 (42.7%) |
Percutaneous endoscopic gastrostomy (PEG) tube insertion | 1 (0.97%) |
Colonoscopy | 25 (24.27%) |
Enteroscopy | 1 (0.97%) |
Endoscopic retrograde cholangiopancreatography (ERCP) | 12 (11.65%) |
Endoscopic ultrasound (EUS) | 7 (6.8%) |
Pigtail | 3 (2.9%) |
Percutaneous transhepatic drainage (PTD) | 2 (1.94%) |
Liver biopsy | 2 (1.94%) |
Radiofrequency ablation (RFA) | 3 (2.9%) |
Trans-arterial chemoembolization (TACE) | 3 (2.9%) |
Procedure emergency | |
Urgent | 24 (23.3%) |
Semi-urgent | 28 (27.2%) |
Elective | 51 (49.5%) |
COVID-19-related symptomatic | 3 (2.9%) |
Fever ≥38°C only | 1 (0.97%) |
Fever ≥ 38°C with dyspnea | 1 (0.97%) |
Fever ≥ 38°C with diarrhea | 1 (0.97%) |
Associated comorbidity | |
Diabetes mellitus | 13 (12.6%) |
Hypertension | 8 (7.76%) |
History of contact with COVID-19 patients | |
Yes | 0 (0%) |
No | 103 (100%) |
Laboratory tests | |
Lymphopenia | 16 (11.1%) |
Elevated CRP | 25 (24.3%) |
Chest CT findings of COVID-19 pneumonia | |
Yes | 2 (1.9%) |
No | 101 (98.1%) |
COVID-19 antibody | |
IgM-positive | 7 (6.8%) |
IgG-positive | 8 (7.8%) |
IgM and IgG-positive | 11 (10.7%) |
IgM and IgG-negative | 77 (74.7%) |
COVID-19 PCR (n=26) | |
Positive | 16 (61.5%) |
Negative | 10 (38.5%) |
COVID-19 infection after the procedures based on symptoms | |
Yes | 0 (0%) |
No | 103 (100%) |